Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Amarglim Plus 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

ASV Laboratories India Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Amarglim Plus 2mg/500mg Tablet

Diabex Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Always take Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital for diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms – sweating, dizziness, headache, trembling – and how to manage them. Consistent meals and readily available fast-acting glucose (e.g., sugary foods, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your physician before starting treatment. Pregnant or breastfeeding individuals must consult their doctor prior to use. Regular blood glucose monitoring, along with blood tests to track blood cell counts and liver function, will be recommended by your physician.

Uses of Amarglim Plus 2mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Amarglim Plus 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Amarglim Plus 2mg/500mg Tablets. Ingest the tablets whole; do not crush, chew, or break them. Administer this medication with a meal.

Common Side effects of Amarglim Plus 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Amarglim Plus 2mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Amarglim Plus 2mg/500mg tablets should be administered with a meal.

How Amarglim Plus 2mg/500mg Tablet works:

Amarglim Plus, a 2mg/500mg tablet, unites glimepiride and metformin to manage diabetes. Glimepiride, a sulfonylurea, boosts insulin secretion from the pancreas, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Amarglim Plus 2mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Amarglim Plus 2mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Amarglim Plus 2mg/500mg tablets while breastfeeding is contraindicated due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Amarglim Plus 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The use of Amarglim Plus 2mg/500mg tablets is contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Amarglim Plus 2mg/500mg tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation with a low dose of Amarglim Plus 2mg/500mg is typical; however, it's contraindicated in severe cases.

What if you forget to take Amarglim Plus 2mg/500mg Tablet :

Should you forget to take your Amarglim Plus 2mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Amarglim Plus 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Amarglim Plus 2mg/500mg Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of Amarglim Plus 2mg/500mg Tablet use. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with impaired kidney function, the elderly, and heavy alcohol consumers. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should any of these symptoms appear, discontinue Amarglim Plus 2mg/500mg Tablet use and seek immediate medical attention.
Amarglim Plus 2mg/500mg tablets contain glimepiride and metformin, acting together to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin decreases liver glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes treatment.
Amarglim Plus 2mg/500mg Tablets may cause common adverse reactions including low blood glucose, taste disturbances, queasiness, abdominal discomfort, loose stools, and cephalalgia. Rare but potentially serious side effects such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged Amarglim Plus 2mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Indeed, Amarglim Plus 2mg/500mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremors. This risk increases with missed or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Amarglim Plus 2mg/500mg tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use also elevates the likelihood of lactic acidosis.
Amarglim Plus 2mg/500mg T...
49
MRP 60
18% off